Johns Hopkins University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Johns Hopkins University sits in the top decile of US sponsors by registered trial count (#14 of 15,751 sponsors by registered trial count).

1,448 total trials 250 currently recruiting 943 completed early-phase tilt top decile by trial count

Johns Hopkins University: 1,448 sponsored US clinical trials, 250 recruiting.

Johns Hopkins University sponsors 1,448 registered US clinical trials on ClinicalTrials.gov, 250 of them currently recruiting, and 943 completed. 125 of these trials are in Phase 3-4 (later-stage) and 399 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 15 trials.

Top-decile sponsor footprint

Johns Hopkins University ranks in the top decile of sponsors by registered trial count (#14 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

1,448 total, page 20 of 29

COMPLETED Phase 3

Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III

NCT01827046

COMPLETED NA

Intervention Trial to Decrease Cardiovascular Risk in Persons With Serious Mental Illness

NCT02127671

COMPLETED NA

Reducing Agitation in People With Dementia: the Customized Activity Trial

NCT01892579

COMPLETED Phase 1

Safety of Clonidine in Infants With Hypoxic Ischemic Encephalopathy During Therapeutic Hypothermia

NCT01862250

COMPLETED NA

Preconception Women's Health in Pediatric Practice Intervention

NCT02049554

COMPLETED NA

A Multi-Center Randomized Controlled Trial of Mentoring to Prevent Youth Violence

NCT01770873

COMPLETED Phase 2

Cognitive Stimulation in Adolescents

NCT01948674

COMPLETED Phase 2

Diabetic Macular Edema Treated With Ozurdex (DMEO)

NCT01951066

TERMINATED Phase 2

Self-Propelled Versus Standard Percutaneous Endoscopic Gastrojejunostomy(PEG-J); RCT

NCT01892267

COMPLETED NA

Achieving Blood Pressure Control Together Study

NCT01902719

COMPLETED NA

Treatment for Caffeine Dependence

NCT01951872

COMPLETED NA

Pilot Study of Navigational Bronchoscopy and Transthoracic Needle Biopsy

NCT02109458

COMPLETED

Biomarkers In Retinitis Pigmentosa (BIRP)

NCT01949623

COMPLETED Phase 1

PET Imaging Study Using [11C]PIB in Subjects With AD & Healthy Volunteers

NCT01826110

COMPLETED NA

Disrupted Sleep, Neuroendocrine Status and the Behavioral Symptoms of AD

NCT01920672

TERMINATED

Efficacy of High Flow Therapy in COPD At Home

NCT02230020

COMPLETED NA

Baby Nutrition and Physical Activity Self-Assessment for Child Care (NAP SACC) Intervention Study

NCT01890681

COMPLETED Phase 4

Diuretics and Dopamine in Heart Failure With Preserved Ejection Fraction

NCT01901809

COMPLETED Phase 1

Study of the Treatment of Experimental Pain in Opioid Dependent Persons on Methadone or Buprenorphine Maintenance

NCT01642030

COMPLETED NA

Interpersonal Psychotherapy for Youth With Severe Mood Dysregulation

NCT01962623

COMPLETED NA

PET Imaging in ALS Patients

NCT02236897

COMPLETED NA

Comparison of Transbronchial, Cryoprobe, and VATS Biopsy for the Diagnosis of Interstitial Lung Disease

NCT02075762

COMPLETED NA

Influenza Diagnosis, Treatment and Surveillance With Xpert Flu

NCT01947049

COMPLETED

Surgical Site Infection Rate After Intra-Abdominal Surgery Using Negative Pressure Wound Therapy at Initial Closure

NCT01924884

COMPLETED Phase 2

A Study of Muscle Strength Maintenance in Older Adults

NCT01989793

COMPLETED Phase 1

Efficacy of Bevacizumab (Avastin) in Treatment of Acute NMO Exacerbations

NCT01777412

COMPLETED

Cerebral Blood Flow During CPB During Cardiac Surgery and the Presence of Post op Delirium

NCT02084394

TERMINATED

Neuroimaging & Plasma Markers for Predicting Outcomes After Mild Traumatic Brain Injury

NCT02891941

COMPLETED NA

Mechanisms of Sleep Disruption Hyperalgesia

NCT01794689

COMPLETED Phase 1

Sargramostim for Myeloid Dendritic Cell Deficiency

NCT01871467

COMPLETED NA

Developing an Integrated Model for Home Visitation

NCT02410109

COMPLETED Phase 1

Pharmacokinetic and Pharmacodynamic Effects of Passive Cannabis Inhalation

NCT01798186

COMPLETED Phase 1

Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators

NCT01988311

TERMINATED Phase 1

Oral Rehydration Therapy in Burn Patients

NCT02124265

COMPLETED NA

Asthma Express: Bridging the Emergency to Primary Care in Underserved Children

NCT01981564

COMPLETED NA

Health Improvement for Baltimore Youth

NCT02624193

COMPLETED NA

Biobehavioral Pain Management in TMD

NCT01794624

COMPLETED NA

Effect of Altered Alarm Settings on Patient Adverse Events and Alarm Signal Frequency

NCT02041858

COMPLETED NA

Examining Cortisol and Alpha Amylase in a Healthy Sample of Youth and Adults

NCT02490280

COMPLETED NA

tDCS Intervention in Primary Progressive Aphasia

NCT02606422

COMPLETED

Impairment of Reading Ability in Dry Eye Patients

NCT01826812

TERMINATED Phase 2

Supplementation With Omega-3: Mechanism of Action

NCT02036307

TERMINATED Phase 4

Glycemia in Diabetic Elders Trial

NCT02029846

TERMINATED NA

Assessment of Penile Vibratory Stimulation Using the Viberect in Men With Mild-Moderate ED

NCT01715571

COMPLETED NA

Modified Atkins Diet Plus KetoCal for Adult Epilepsy

NCT01834482

COMPLETED NA

Taste Acuity and Caloric Intake After Acute Morphine Administration

NCT01763697

TERMINATED NA

IL-10 Levels and Remote Ischemic Preconditioning in Acute Myocardial Infarction

NCT01532206

TERMINATED NA

Effects of Meditation

NCT01827033

COMPLETED NA

Identification of TT Cases by Community Treatment Assistants: An Assessment

NCT01783743

COMPLETED Phase 2

American Ginseng to Improve HIV-Associated Fatigue: A Randomized, Placebo-Controlled, Parallel Design, Multiple-Dose Clinical Trial

NCT01500096

← Previous Page 20 of 29 Next →

Phase Distribution

PhaseTrial count
Phase 1 201
Phase 2 198
Phase 3 44
Phase 4 81

What is open in the Johns Hopkins University pipeline

250 recruiting of 1,448 indexed (17% open); 943 completed (65%).

Phase mix: 125 late (III/IV) vs 399 early (I/II) (early-phase heavy).

Top condition: Hypertension (15 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.